Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Worel, N; Greinix, HT; Leitner, G; Mitterbauer, M; Rabitsch, W; Rosenmayr, A; Höcker, P; Kalhs, P.
ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathy.
Transfus Apher Sci. 2007; 36(3): 297-304. Doi: 10.1016/j.transci.2007.03.004
Web of Science PubMed FullText FullText_MUG

 

Co-Autor*innen der Med Uni Graz
Greinix Hildegard
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Transplant-associated microangiopathy (TAM) is a severe complication following allogeneic hematopoietic stem cell transplantation (HSCT) even after reduced-intensity conditioning (RIC). Data on 112 patients following RIC were analyzed with respect to TAM according to the ASBMT and risk factors, response to well-defined therapy and outcome were determined. TAM occurred in 11 of 112 patients. Univariate analysis determined acute graft-versus-host disease and ABO-incompatibility as risk factors for TAM. Treatment consisted of withdrawal of calcineurin inhibitors and plasma exchange (PE). Response to PE was 64%. PE seems to be an effective therapeutic option that should be assessed in larger patient cohorts.
Find related publications in this database (using NLM MeSH Indexing)
ABO Blood-Group System - immunology
Adolescent -
Adult -
Aged -
Blood Group Incompatibility - complications
Female -
Graft vs Host Disease -
Hematopoietic Stem Cell Transplantation - adverse effects Hematopoietic Stem Cell Transplantation - methods
Humans -
Male -
Microcirculation -
Microvessels - pathology
Middle Aged -
Peripheral Vascular Diseases - etiology Peripheral Vascular Diseases - therapy
Plasma Exchange -
Risk Factors -
Transplantation Conditioning - methods
Transplantation, Homologous -
Treatment Outcome -
Young Adult -

© Med Uni Graz Impressum